Cargando…

The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro

Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the demands of testing and reduce transmission, SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohmer, Niko, Toptan, Tuna, Pallas, Christiane, Karaca, Onur, Pfeiffer, Annika, Westhaus, Sandra, Widera, Marek, Berger, Annemarie, Hoehl, Sebastian, Kammel, Martin, Ciesek, Sandra, Rabenau, Holger F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830733/ https://www.ncbi.nlm.nih.gov/pubmed/33477365 http://dx.doi.org/10.3390/jcm10020328

Ejemplares similares

Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus
por: Roesmann, Fabian, et al.
Publicado: (2023)

Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
por: Toptan, Tuna, et al.
Publicado: (2020)

Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
por: Kohmer, Niko, et al.
Publicado: (2021)

Clinical performance of different SARS‐CoV‐2 IgG antibody tests
por: Kohmer, Niko, et al.
Publicado: (2020)

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
por: Kohmer, Niko, et al.
Publicado: (2020)

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
por: Wilhelm, Alexander, et al.
Publicado: (2022)

Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination
por: Grikscheit, Katharina, et al.
Publicado: (2022)

Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
por: Kohmer, Niko, et al.
Publicado: (2022)

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
por: Toptan, Tuna, et al.
Publicado: (2021)

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Kohmer, Niko, et al.
Publicado: (2021)

Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7
por: Widera, Marek, et al.
Publicado: (2021)

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
por: Kohmer, Niko, et al.
Publicado: (2023)

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q
por: Wilhelm, Alexander, et al.
Publicado: (2021)

Reply to Fabbris et al. A Viable Alternative. Comment on “Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751”
por: Hoehl, Sebastian, et al.
Publicado: (2022)

Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage
por: Kohmer, Niko, et al.
Publicado: (2021)

Increasing but insufficient neutralizing activity against Omicron-BA.1 after a second booster dose of mRNA-1273 vaccine in chronic haemodialysis patients
por: Ovcar, Eugen, et al.
Publicado: (2022)

Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients
por: Ovcar, Eugen, et al.
Publicado: (2023)

Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination
por: Delbrück, Marla, et al.
Publicado: (2022)

Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
por: Koehm, Michaela, et al.
Publicado: (2023)

Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication
por: Widera, Marek, et al.
Publicado: (2021)

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
por: Veleanu, Andrei, et al.
Publicado: (2022)

SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach
por: Layer, Emily, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response
por: Lammert, Alexander, et al.
Publicado: (2022)

Detection of SARS-CoV-2 in raw and treated wastewater in Germany – Suitability for COVID-19 surveillance and potential transmission risks
por: Westhaus, Sandra, et al.
Publicado: (2021)

Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population
por: Schmidt, Michael, et al.
Publicado: (2020)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
por: Patyna, Sammy, et al.
Publicado: (2022)

Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?
por: Hoehl, Sebastian, et al.
Publicado: (2023)

A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated
por: Hoehl, Sebastian, et al.
Publicado: (2021)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Die Virologie von SARS-CoV-2
por: Hoehl, S., et al.
Publicado: (2020)

Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection
por: Weiss, Roxanne, et al.
Publicado: (2021)

Machine learning on large scale perturbation screens for SARS-CoV-2 host factors identifies β-catenin/CBP inhibitor PRI-724 as a potent antiviral
por: Kelch, Maximilian A., et al.
Publicado: (2023)

Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020
por: Muenchhoff, Maximilian, et al.
Publicado: (2020)

Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
por: Hoehl, Sebastian, et al.
Publicado: (2020)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022)

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
por: Bojkova, Denisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_07o6dq1osr7r10re418orq7sfs